According to a recent Yale study, cancer cells with extra chromosomes depend on those chromosomes for tumour growth, and eliminating them prevents the cells from developing into tumours. The researchers' findings suggest that a unique strategy for treating cancer may involve selectively targ
A new Yale study found that cancer cells with extra chromosomes rely on those chromosomes for tumour formation, and eliminating them prevents the cells from developing tumours. The findings suggested the prospect of a revolutionary cancer therapy technique that selectively targets extra chro
A new study done by experts at The University of Texas MD Anderson Cancer Centre provides a deeper understanding of the development of the tumour microenvironment throughout the progression of gastric cancer. Two of the study's notable discoveries include a potential therapy target and a lin
Scientists have developed an AI tool that can instantly decode a brain tumour's DNA to determine its molecular identification during surgery - vital information that can take a few days to a few weeks under the present approach.
Scientists have developed an AI tool that can rapidly decode a brain tumour's DNA to determine its molecular identity during surgery, critical information that can take a few days to a few weeks under the current approach.
Cancer cells with extra chromosomes rely on those chromosomes for tumour growth, according to a new Yale study, and removing them inhibits the cells from becoming tumours. According to the researchers, the findings show that specifically targeting additional chromosomes may offer a novel app
According to a recent Yale study, cancer cells with additional chromosomes rely on those chromosomes for tumour formation, and removing them stops the cells from growing tumours. The results, according to the researchers, point to the possibility of a novel cancer treatment strategy that spe
During the advancement of stomach cancer, a new study headed by scientists at The University of Texas MD Anderson Cancer Centre offers a better knowledge of the evolution of the tumour microenvironment. A new treatment target and a connection between multicellular communities and clinical ou
Cancer spreads in devious, almost military ways across the human body. It may, for example, alter our genetic make-up, take over certain cell-to-cell signalling mechanisms, and change essential enzymes to enhance tumour development, resistance to medicines, and expedite spread from the initi
Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to identify folate receptors in brain tumours. The identification of folate receptors and its potential application in brain tumours is a fresh and significant scientific breakthrough.
Immunotherapy is a relatively new and successful cancer treatment. It causes the immune system to identify tumours as invaders and attack them. Immunotherapy, however, does not benefit all patients. Why? Scientists aren't always certain.
Sometimes, immunotherapy patients experience side eff
Immunotherapy is one of the most recent and effective cancer treatments. It causes the immune system to identify tumours as intruders in the body and attack them. However, not all patients benefit from immunotherapy. Why? Scientists are not always sure.